Abstract
Cancer is a major public health problem worldwide. Among the treatments used, Doxorubicin (DXO) stands out, a drug used to treat various types of tumors. Despite its effectiveness, DXO has cardiotoxicity as an adverse effect. It is classically accepted that oxidative stress plays a role in the damage mechanism of secondary toxicity of DXO. In order to mitigate and/or prevent cardiotoxicit…